AGWCA
DXCM icon

Annis Gardner Whiting Capital Advisors’s DexCom DXCM Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Sell
5,646
-90
-2% -$6K 0.06% 248
2026
Q1 		$360K Buy
5,736
+46
+0.8% +$3.2K 0.06% 228
2025
Q4 		$378K Sell
5,690
-1,554
-21% -$100K 0.07% 215
2025
Q3 		$487K Buy
7,244
+7,137
+6,670% +$565K 0.1% 165
2025
Q2 		$9.34K Buy
107
+97
+970% +$7.6K ﹤0.01% 734
2025
Q1 		$683 Sell
10
-3,683
-100% -$301K ﹤0.01% 725
2024
Q4 		$287K Buy
3,693
+98
+3% +$7.26K 0.08% 181
2024
Q3 		$241K Buy
3,595
+3,215
+846% +$264K 0.07% 195
2024
Q2 		$43.1K Sell
380
-30
-7% -$3.79K 0.01% 425
2024
Q1 		$56.9K Buy
+410
New +$51.5K 0.02% 366

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's DXCM Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its DexCom (DXCM) stake by 1.6% in Q2 2026, selling an estimated $6K and leaving 5,646 shares worth $380K. The position accounts for 0.06% of the portfolio, ranked #248.

Annis Gardner Whiting Capital Advisors first reported a position in DXCM in Q1 2024 and has held it in 10 quarters since. The position peaked at $487K in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 5,646 shares of DexCom worth $380K as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors sold 90 DexCom shares in Q2 2026, an estimated $6K.
  • DexCom made up 0.06% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #248 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in DexCom in Q1 2024 and has held it in 10 quarters since.
  • Annis Gardner Whiting Capital Advisors's DexCom position peaked at $487K in Q3 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.